Brain-site-specific proteome changes induced by neuronal P60TRP expression

NeuroSignals

Volumn 21, Issue 3-4, 2013, Pages 129-149

  Manavalan, Arulmani ^a,b   Mishra, Manisha ^a,b   Sze, Siu Kwan ^a   Heese, Klaus ^c  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c Hanyang University   (South Korea)

Author keywords

Brain; Cortex; GPRASP; Hippocampus; Metabolism; p60 transcription regulator protein

Indexed keywords

MEMBRANE PROTEIN; P60 TRANSCRIPTION REGULATOR PROTEIN; PROTEOME; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 3; ALPHA SYNUCLEIN; BETA SYNUCLEIN; CADHERIN 2; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; DMX LIKE PROTEIN 2; GLUTAMATE RECEPTOR 2; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MICROTUBULE ASSOCIATED PROTEIN 2; NADH DEHYDROGENASE (UBIQUINONE) FLAVOPROTEIN 2; POSTSYNAPTIC DENSITY PROTEIN 95; POTASSIUM CHLORIDE COTRANSPORTER 2; RAN SPECIFIC GTPASE ACTIVATING PROTEIN; RAS AND RAB INTERACTOR 1; REGULATOR PROTEIN; SEPTIN 2; SEPTIN 6; SEPTIN 9; SYNAPSIN 2; SYNAPTOJANIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; COGNITION; FEMALE; GENE OVEREXPRESSION; HIPPOCAMPUS; IN VIVO STUDY; MALE; MEDICAL RESEARCH; MOUSE; NERVE FUNCTION; NEUROPROTECTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; FEMALE; MALE; MICE; MICE, TRANSGENIC; NEURONS; PROTEOME;

EID: 84878010756     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000343672     Document Type: Article

References (113)

1. Abu-Helo A, Simonin F: Identification and biological significance of G protein-coupled receptor associated sorting proteins (GASPs). Pharmacol Ther 2010; 126: 244-250.
2. Moser E, Kargl J, Whistler JL, Waldhoer M, Tschische P: G protein-coupled receptorassociated sorting protein 1 regulates the postendocytic sorting of seven-transmembrane- spanning G protein-coupled receptors. Pharmacology 2010; 86: 22-29.
3. Heese K, Yamada T, Akatsu H, Yamamoto T, Kosaka K, Nagai Y, Sawada T: Characterizing the new transcription regulator protein p60TRP. J Cell Biochem 2004; 91: 1030-1042.
4. Mishra M, Heese K: p60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis. J Cell Mol Med 2011; 15: 2462-2477.
5. Mishra M, Akatsu H, Heese K: The novel protein mani modulates neurogenesis and neurite-cone growth. J Cell Mol Med 2011; 15: 1713-1725.
6. Mishra M, Manavalan A, Sze SK, Heese K: Neuronal p60TRP expression modulates cardiac capacity. J Proteomics 2012; 75: 1600- 1617.
7. Sundaramurthi H, Manavalan A, Ramachandran U, Hu JM, Sze SK, Heese K: Phenotyping of tianma-stimulated differentiated rat neuronal b104 cells by quantitative proteomics. Neurosignals 2012; 20: 48-60.
8. Shen Y, Inoue N, Heese K: Neurotrophin-4 (NTF4) mediates neurogenesis in mouse embryonic neural stem cells through the inhibition of the signal transducer and activator of transcription-3 (Stat3) and the modulation of the activity of protein kinase B. Cell Mol Neurobiol 2010; 30: 909-916.
9. Islam O, Loo TX, Heese K: Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res 2009; 6: 42-53.
10. Hiller K, Schobert M, Hundertmark C, Jahn D, Munch R: Jvirgel: Calculation of virtual two-dimensional protein gels. Nucleic Acids Res 2003; 31: 3862-3865.
11. Cheung ZH, Ip NY: The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol J 2007; 2: 949-957.
12. Yang Y, Kim AH, Bonni A: The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20- APC regulate neuronal morphogenesis and connectivity. Curr Opin Neurobiol 2010; 20: 92-99.
13. Lee HK, Kirkwood A: AMPA receptor regulation during synaptic plasticity in hippocampus and neocortex. Semin Cell Dev Biol 2011; 22: 514-520.
14. Ripley B, Otto S, Tiglio K, Williams ME, Ghosh A: Regulation of synaptic stability by AMPA receptor reverse signaling. Proc Natl Acad Sci USA 2011; 108: 367-372.
15. Corti C, Xuereb JH, Crepaldi L, Corsi M, Michielin F, Ferraguti F: Altered levels of glutamatergic receptors and Na + /K + ATPasealpha1 in the prefrontal cortex of subjects with schizophrenia. Schizophr Res 2011; 128: 7-14.
16. Carney DS, Davies BA, Horazdovsky BF: Vps9 domain-containing proteins: activators of Rab5 GTPases from yeast to neurons. Trends Cell Biol 2006; 16: 27-35.
17. Galvis A, Giambini H, Villasana Z, Barbieri MA: Functional determinants of Ras interference mutants required for their inhbitory activity on endocytosis. Exp Cell Res 2009; 315: 820-835.
18. Galvis A, Balmaceda V, Giambini H, Conde A, Villasana Z, Fornes MW, Barbieri MA: Inhibition of early endosome fusion by Rab5-binding defective Ras interference 1 mutants. Arch Biochem Biophys 2009; 482: 83-95.
19. Kong C, Su X, Chen PI, Stahl PD: Rin1 interacts with signal-transducing adaptor molecule (STAM) and mediates epidermal growth factor receptor trafficking and degradation. J Biol Chem 2007; 282: 15294-15301.
20. Bliss JM, Gray EE, Dhaka A, O'Dell TJ, Colicelli J: Fear learning and extinction are linked to neuronal plasticity through Rin1 signaling. J Neurosci Res 2010; 88: 917-926.
21. Dzudzor B, Huynh L, Thai M, Bliss JM, Nagaoka Y, Wang Y, Ch'ng TH, Jiang M, Martin KC, Colicelli J: Regulated expression of the Ras effector Rin1 in forebrain neurons. Mol Cell Neurosci 2010; 43: 108-116.
22. Wang Y, Waldron RT, Dhaka A, Patel A, Riley MM, Rozengurt E, Colicelli J: The Ras effector Rin1 directly competes with Raf and is regulated by 14-3-3 proteins. Mol Cell Biol 2002; 22: 916-926.
23. Dhaka A, Costa RM, Hu H, Irvin DK, Patel A, Kornblum HI, Silva AJ, O'Dell TJ, Colicelli J: The Ras effector Rin1 modulates the formation of aversive memories. J Neurosci 2003; 23: 748-757.
24. Deininger K, Eder M, Kramer ER, Zieglgansberger W, Dodt HU, Dornmair K, Colicelli J, Klein R: The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proc Natl Acad Sci USA 2008; 105: 12539-12544.
25. Kawabe H, Sakisaka T, Yasumi M, Shingai T, Izumi G, Nagano F, Deguchi-Tawarada M, Takeuchi M, Nakanishi H, Takai Y: A novel rabconnectin-3-binding protein that directly binds a GDP/GTP exchange protein for Rab3A small G protein implicated in Ca(2+)- dependent exocytosis of neurotransmitter. Genes Cells 2003; 8: 537-546.
26. Nagano F, Kawabe H, Nakanishi H, Shinohara M, Deguchi-Tawarada M, Takeuchi M, Sasaki T, Takai Y: Rabconnectin-3, a novel protein that binds both GDP/GTP exchange protein and GTPase-activating protein for Rab3 small G protein family. J Biol Chem 2002; 277: 9629-9632.
27. Sethi N, Yan Y, Quek D, Schupbach T, Kang Y: Rabconnectin-3 is a functional regulator of mammalian notch signaling. J Biol Chem 2010; 285: 34757-34764.
28. Kageyama R, Niwa Y, Shimojo H: Rhythmic gene expression in somite formation and neural development. Mol Cells 2009; 27: 497- 502.
29. Zhu X, Zhang J, Tollkuhn J, Ohsawa R, Bresnick EH, Guillemot F, Kageyama R, Rosenfeld MG: Sustained notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes Dev 2006; 20: 2739-2753.
30. Mosevitsky MI, Capony JP, Skladchikova G, Novitskaya VA, Plekhanov A, Zakharov VV: The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties. Biochimie 1997; 79: 373-384.
31. Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR: Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXB1 and BASP1 protein expression. Mol Psychiatry 2009; 14: 601-613.
32. Anwar S, Peters O, Millership S, Ninkina N, Doig N, Connor-Robson N, Threlfell S, Kooner G, Deacon RM, Bannerman DM, Bolam JP, Chandra SS, Cragg SJ, Wade-Martins R, Buchman VL: Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci 2011; 31: 7264-7274.
33. Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC, Petrlova J, Voss JC, Stamou DG, Steven AC, Langen R: Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem 2010; 285: 32486- 32493.
34. Beyer K, Ispierto L, Latorre P, Tolosa E, Ariza A: Alpha- and beta-synuclein expression in Parkinson disease with and without dementia. J Neurol Sci 2011; 310: 112-117.
35. Beyer K, Munoz-Marmol AM, Sanz C, Marginet- Flinch R, Ferrer I, Ariza A: New brainspecific beta-synuclein isoforms show expression ratio changes in Lewy body diseases. Neurogenetics 2012; 13: 61-72.
36. Shaltiel-Karyo R, Frenkel-Pinter M, Egoz- Matia N, Frydman-Marom A, Shalev DE, Segal D, Gazit E: Inhibiting alpha-synuclein oligomerization by stable cell-penetrating beta-synuclein fragments recovers phenotype of Parkinson's disease model flies. PLoS One 2010; 5:e13863.
37. Ide M, Lewis DA: Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol Psychiatry 2010; 68: 25-32.
38. Spiliotis ET: Regulation of microtubule organization and functions by septin GTPases. Cytoskeleton (Hoboken) 2010; 67: 339-345.
39. Ito H, Atsuzawa K, Morishita R, Usuda N, Sudo K, Iwamoto I, Mizutani K, Katoh-Semba R, Nozawa Y, Asano T, Nagata K: Sept8 controls the binding of vesicle-associated membrane protein 2 to synaptophysin. J Neurochem 2009; 108: 867-880.
40. Peterson EA, Petty EM: Conquering the complex world of human septins: implications for health and disease. Clin Genet 2010; 77: 511-524.
41. Hall PA, Russell SE: The pathobiology of the septin gene family. J Pathol 2004; 204: 489- 505.
42. Roeseler S, Sandrock K, Bartsch I, Zieger B: Septins, a novel group of GTP-binding proteins: relevance in hemostasis, neuropathology and oncogenesis. Klin Pädiatr 2009; 221: 150-155.
43. Tsang CW, Estey MP, DiCiccio JE, Xie H, Patterson D, Trimble WS: Characterization of presynaptic septin complexes in mammalian hippocampal neurons. Biol Chem 2011; 392: 739-749.
44. Buser AM, Erne B, Werner HB, Nave KA, Schaeren-Wiemers N: The septin cytoskeleton in myelinating glia. Mol Cell Neurosci 2009; 40: 156-166.
45. Ludwig A, Uvarov P, Soni S, Thomas-Crusells J, Airaksinen MS, Rivera C: Early growth response 4 mediates BDNF induction of potassium chloride cotransporter 2 transcription. J Neurosci 2011; 31: 644-649.
46. Horn Z, Ringstedt T, Blaesse P, Kaila K, Herlenius E: Premature expression of KCC2 in embryonic mice perturbs neural development by an ion transport-independent mechanism. Eur J Neurosci 2010; 31: 2142- 2155.
47. Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG: Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis 2010; 1:e2.
48. Li X, Wang QJ, Pan N, Lee S, Zhao Y, Chait BT, Yue Z: Phosphorylation-dependent 14-3- binding to LRRK2 is impaired by common mutations of familial Parkinson's disease. PLoS One 2011; 6:e17153.
49. Radhakrishnan VM, Martinez JD: 14-3-3 gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. PLoS One 2010; 5:e11433.
50. McFarland MA, Ellis CE, Markey SP, Nussbaum RL: Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics 2008; 7: 2123-2137.
51. Lee CM, Stevens LA, Hsu HC, Tsai SC, Lee YT, Moss J, Vaughan M: Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport. J Mol Cell Cardiol 1996; 28: 1911-1920.
52. Cockcroft S, Thomas GM, Fensome A, Geny B, Cunningham E, Gout I, Hiles I, Totty NF, Truong O, Hsuan JJ: Phospholipase D: a downstream effector of ARF in granulocytes. Science 1994; 263: 523-526.
53. Suzuki I, Owada Y, Suzuki R, Yoshimoto T, Kondo H: Localization of mRNAs for six ARFs (ADP-ribosylation factors) in the brain of developing and adult rats and changes in the expression in the hypoglossal nucleus after its axotomy. Brain Res Mol Brain Res 2001; 88: 124-134.
54. Braun A, Breuss M, Salzer MC, Flint J, Cowan NJ, Keays DA: Tuba8 is expressed at low levels in the developing mouse and human brain. Am J Hum Genet 2010; 86: 819-822, author reply 822-813.
55. Vazquez-Higuera JL, Mateo I, Sanchez-Juan P, Rodriguez-Rodriguez E, Pozueta A, Calero M, Dobato JL, Frank-Garcia A, Valdivieso F, Berciano J, Bullido MJ, Combarros O: Genetic variation in the tau protein phosphatase- 2a pathway is not associated with Alzheimer's disease risk. BMC Res Notes 2011; 4: 327.
56. Rekart JL, Routtenberg A: Overexpression of GAP-43 reveals unexpected properties of hippocampal mossy fibers. Hippocampus 2010; 20: 46-57.
57. Foscarin S, Gianola S, Carulli D, Fazzari P, Mi S, Tamagnone L, Rossi F: Overexpression of GAP-43 modifies the distribution of the receptors for myelin-associated growth-inhibitory proteins in injured Purkinje axons. Eur J Neurosci 2009; 30: 1837-1848.
58. Hannappel E, Huff T: The thymosins. Prothymosin alpha, parathymosin, and betathymosins: structure and function. Vitam Horm 2003; 66: 257-296.
59. Martic G, Karetsou Z, Kefala K, Politou AS, Clapier CR, Straub T, Papamarcaki T: Parathymosin affects the binding of linker histone H1 to nucleosomes and remodels chromatin structure. J Biol Chem 2005; 280: 16143-16150.
60. Doyle GA, Dahl JP, Bloch PJ, Weller AE, Lohoff FW, Ferraro TN, Berrettini WH: Association study of polymorphisms in the autosomal mitochondrial complex I subunit gene, NADH dehydrogenase (ubiquinone) flavoprotein 2, and bipolar disorder. Psychiatr Genet 2011; 21: 51-52.
61. Zhang W, Chen X, Gong W, Tang J, Tan L, Guo H, Yao YG: Common promoter variants of the NDUVF2 gene do not confer susceptibility to schizophrenia in Han chinese. Behav Brain Funct 2010; 6: 75.
62. Nishioka K, Vilarino-Guell C, Cobb SA, Kachergus JM, Ross OA, Hentati E, Hentati F, Farrer MJ: Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 686-687.
63. Washizuka S, Iwamoto K, Kakiuchi C, Bundo M, Kato T: Expression of mitochondrial complex I subunit gene NDUVF2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci Res 2009; 63: 199-204.
64. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW: Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2009; 259: 151-163.
65. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, Maccarrone G, Turck CW, Dias-Neto E: Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm 2009; 116: 275-289.
66. Mizuta I, Tsunoda T, Satake W, Nakabayashi Y, Watanabe M, Takeda A, Hasegawa K, Nakashima K, Yamamoto M, Hattori N, Murata M, Toda T: Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease. Hum Genet 2008; 124: 89-94.
67. Silverman JB, Restituito S, Lu W, Lee-Edwards L, Khatri L, Ziff EB: Synaptic anchorage of AMPA receptors by cadherins through neural plakophilin-related ARM protein AMPA receptor-binding protein complexes. J Neurosci 2007; 27: 8505-8516.
68. Zhang J, Petit CM, King DS, Lee AL: Phosphorylation of a PDZ domain extension modulates binding affinity and interdomain interactions in postsynaptic density-95 (PSD-95) protein, a membrane-associated guanylate kinase (MAGUK). J Biol Chem 2011; 286: 41776-41785.
69. Gottschalk M, Bach A, Hansen JL, Krogsgaard- Larsen P, Kristensen AS, Stromgaard K: Detecting protein-protein interactions in living cells: development of a bioluminescence resonance energy transfer assay to evaluate the PSD-95/NMDA receptor interaction. Neurochem Res 2009; 34: 1729-1737.
70. Gardoni F: MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol 2008; 585: 147-152.
71. Cousins SL, Papadakis M, Rutter AR, Stephenson FA: Differential interaction of NMDA receptor subtypes with the post-synaptic density-95 family of membrane associated guanylate kinase proteins. J Neurochem 2008; 104: 903-913.
72. Funk AJ, Rumbaugh G, Harotunian V, Mc- Cullumsmith RE, Meador-Woodruff JH: Decreased expression of NMDA receptorassociated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport 2009; 20: 1019-1022.
73. Sultana R, Banks WA, Butterfield DA: Decreased levels of PSD95 and two associated proteins and increased levels of BCL2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: insights into their potential roles for loss of synapses and memory, accumulation of abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res 2010; 88: 469-477.
74. Proctor DT, Coulson EJ, Dodd PR: Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology. J Alzheimers Dis 2010; 21: 795-811.
75. Leuba G, Savioz A, Vernay A, Carnal B, Kraftsik R, Tardif E, Riederer I, Riederer BM: Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. J Alzheimers Dis 2008; 15: 139-151.
76. Yoshii A, Murata Y, Kim J, Zhang C, Shokat KM, Constantine-Paton M: Trkb and protein kinase Mzeta regulate synaptic localization of PSD-95 in developing cortex. J Neurosci 2011; 31: 11894-11904.
77. Molnar E: Long-term potentiation in cultured hippocampal neurons. Semin Cell Dev Biol 2011; 22: 506-513.
78. Kolarow R, Brigadski T, Lessmann V: Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci 2007; 27: 10350-10364.
79. Yamasaki N, Maekawa M, Kobayashi K, Kajii Y, Maeda J, Soma M, Takao K, Tanda K, Ohira K, Toyama K, Kanzaki K, Fukunaga K, Sudo Y, Ichinose H, Ikeda M, Iwata N, Ozaki N, Suzuki H, Higuchi M, Suhara T, Yuasa S, Miyakawa T: Alpha-CAMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain 2008; 1: 6.
80. Hegde AN: The ubiquitin-proteasome pathway and synaptic plasticity. Learn Mem 2010; 17: 314-327.
81. Djakovic SN, Schwarz LA, Barylko B, DeMartino GN, Patrick GN: Regulation of the proteasome by neuronal activity and calcium/ calmodulin-dependent protein kinase II. J Biol Chem 2009; 284: 26655-26665.
82. Fitzgerald PJ: The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation. Behav Brain Res 2012; 230: 291-298.
83. Lau A, Tymianski M: Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010; 460: 525-542.
84. Wang Y, Qin ZH: Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010; 15: 1382-1402.
85. Zhang XM, Zhu J: Kainic acid-induced neurotoxicity: targeting glial responses and gliaderived cytokines. Curr Neuropharmacol 2011; 9: 388-398.
86. Carri MT, Cozzolino M: Sod1 and mitochondria in ALS: a dangerous liaison. J Bioenerg Biomembr 2011; 43: 593-599.
87. Contestabile A: Amyotrophic lateral sclerosis: from research to therapeutic attempts and therapeutic perspectives. Curr Med Chem 2011; 18: 5655-5665.
88. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S: Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 2001; 497: 1-5.
89. Sandrock K, Bartsch I, Blaser S, Busse A, Busse E, Zieger B: Characterization of human septin interactions. Biol Chem 2011; 392: 751-761.
90. Sudo K, Ito H, Iwamoto I, Morishita R, Asano T, Nagata K: SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin- signaling. Hum Mutat 2007; 28: 1005- 1013.
91. Hannibal MC, Ruzzo EK, Miller LR, Betz B, Buchan JG, Knutzen DM, Barnett K, Landsverk ML, Brice A, LeGuern E, Bedford HM, Worrall BB, Lovitt S, Appel SH, Andermann E, Bird TD, Chance PF: SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology 2009; 72: 1755-1759.
92. Kuhlenbaumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, Watts GD, De Vriendt E, Young P, Stogbauer F, Halfter H, Irobi J, Goossens D, Del-Favero J, Betz BG, Hor H, Kurlemann G, Bird TD, Airaksinen E, Mononen T, Serradell AP, Prats JM, Van Broeckhoven C, De Jonghe P, Timmerman V, Ringelstein EB, Chance PF: Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 2005; 37: 1044- 1046.
93. Storlazzi CT, Brekke HR, Mandahl N, Brosjo O, Smeland S, Lothe RA, Mertens F: Identification of a novel amplicon at distal 17q containing the BIRC5/survivin gene in malignant peripheral nerve sheath tumours. J Pathol 2006; 209: 492-500.
94. Woscholski R, Finan PM, Radley E, Totty NF, Sterling AE, Hsuan JJ, Waterfield MD, Parker PJ: Synaptojanin is the major constitutively active phosphatidylinositol-3,4,5- trisphosphate 5-phosphatase in rodent brain. J Biol Chem 1997; 272: 9625-9628.
95. Lee SY, Wenk MR, Kim Y, Nairn AC, De Camilli P: Regulation of synaptojanin 1 by cyclin- dependent kinase 5 at synapses. Proc Natl Acad Sci USA 2004; 101: 546-551.
96. Voronov SV, Frere SG, Giovedi S, Pollina EA, Borel C, Zhang H, Schmidt C, Akeson EC, Wenk MR, Cimasoni L, Arancio O, Davisson MT, Antonarakis SE, Gardiner K, De Camilli P, Di Paolo G: Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome. Proc Natl Acad Sci USA 2008; 105: 9415-9420.
97. Saito T, Guan F, Papolos DF, Lau S, Klein M, Fann CS, Lachman HM: Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatry 2001; 6: 387-395.
98. Lea W, Abbas AS, Sprecher H, Vockley J, Schulz H: Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids. Biochim Biophys Acta 2000; 1485: 121- 128.
99. Treem WR, Stanley CA, Hale DE, Leopold HB, Hyams JS: Hypoglycemia, hypotonia, and cardiomyopathy: the evolving clinical picture of long-chain acyl-CoA dehydrogenase deficiency. Pediatrics 1991; 87: 328- 333.
100. He M, Pei Z, Mohsen AW, Watkins P, Murdoch G, Van Veldhoven PP, Ensenauer R, Vockley J: Identification and characterization of new long chain acyl-CoA dehydrogenases. Mol Genet Metab 2011; 102: 418- 429.
101. Ensenauer R, He M, Willard JM, Goetzman ES, Corydon TJ, Vandahl BB, Mohsen AW, Isaya G, Vockley J: Human acyl-CoA dehydrogenase-plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids. J Biol Chem 2005; 280: 32309- 32316.
102. Luo L: Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000; 1: 173-180.
103. Hirose M, Ishizaki T, Watanabe N, Uehata M, Kranenburg O, Moolenaar WH, Matsumura F, Maekawa M, Bito H, Narumiya S: Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-cells. J Cell Biol 1998; 141: 1625-1636.
104. Vega IE, Hsu SC: The septin protein Nedd5 associates with both the exocyst complex and microtubules and disruption of its GTPase activity promotes aberrant neurite sprouting in PC12 cells. Neuroreport 2003; 14: 31-37.
105. Kapitein LC, Yau KW, Gouveia SM, van der Zwan WA, Wulf PS, Keijzer N, Demmers J, Jaworski J, Akhmanova A, Hoogenraad CC: NMDA receptor activation suppresses microtubule growth and spine entry. J Neurosci 2011; 31: 8194-8209.
106. Webster MJ, Elashoff M, Weickert CS: Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int J Dev Neurosci 2011; 29: 225-236.
107. Fanara P, Husted KH, Selle K, Wong PY, Banerjee J, Brandt R, Hellerstein MK: Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice. Neuroscience 2010; 168: 167-178.
108. Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P: Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease. Brain Res 2012; 1432: 95-113.
109. Schulz-Schaeffer WJ: The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol 2010; 120: 131-143.
110. Yasuda T, Mochizuki H: The regulatory role of alpha-synuclein and parkin in neuronal cell apoptosis: possible implications for the pathogenesis of Parkinson's disease. Apoptosis 2010; 15: 1312-1321.
111. Cheng F, Li X, Li Y, Wang C, Wang T, Liu G, Baskys A, Ueda K, Chan P, Yu S: Alphasynuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death. J Neurochem 2011; 119: 815-825.
112. Sherer TB, Betarbet R, Greenamyre JT: Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2001; 2: 657-662.
113. Huls S, Hogen T, Vassallo N, Danzer KM, Hengerer B, Giese A, Herms J: AMPA-receptor- mediated excitatory synaptic transmission is enhanced by iron-induced alpha- synuclein oligomers. J Neurochem 2011; 117: 868-878.